## DD: DuPont de Nemours, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -0.7% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.56)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Insider Selling: DuPont de Nemours (NYSE:DD) CEO Sells 9,011 Shares of Stock**
- Source: MarketBeat | 20251202T225620 | Neutral | Relevance: 100%
- DuPont de Nemours CEO Lori Koch sold 9,011 shares of company stock for over $355,000, reducing her stake by 3.03%. This sale precedes a recently authorized $2.00 billion share buyback program, while analysts have significantly lowered price targets for DD, though still maintaining a "Moderate Buy" consensus rating.

**2. DuPont (DD) director adds 1,267 shares through dividend reinvestment in Form 4**
- Source: Stock Titan | 20251202T163300 | Neutral | Relevance: 100%
- A DuPont de Nemours, Inc. director, Alexander M. Cutler, acquired 1,267.7484 shares of DuPont common stock on November 26, 2025, at a price of $39.44 per share through dividend reinvestment. This transaction increased the director's directly held stake to 75,473.223 shares. The Form 4 filing indicates that cash dividends were automatically used to purchase the additional shares.

**3. DuPont (DD) CEO exercises 9,011 options and sells 9,011 shares in Nov 2025**
- Source: Stock Titan | 20251201T165700 | Somewhat-Bearish | Relevance: 100%
- DuPont's CEO and director, Lori Koch, exercised 9,011 stock options at $28 per share and subsequently sold 9,011 shares of common stock at a weighted average price of $39.4619 on November 28, 2025. Following these transactions, the CEO directly owns 288,325.6878 shares of DuPont common stock. The exercised options were non-qualified, granted in 2019, and set to expire in 2026.

**4. Mackenzie Financial Corp Has $16.26 Million Stock Position in DuPont de Nemours, Inc. $DD**
- Source: MarketBeat | 20251203T120616 | Neutral | Relevance: 100%
- Mackenzie Financial Corp reduced its stake in DuPont de Nemours by 10.8% to 236,997 shares, valued at $16.26 million. Meanwhile, DuPont's board approved a $2.00 billion stock buyback program, indicating a belief that the stock may be undervalued, and the company recently cut its quarterly dividend to $0.20 per share. Institutional ownership of DuPont de Nemours stands at 73.96%, with several analysts weighing in on the stock, resulting in a "Moderate Buy" consensus rating.

**5. DuPont de Nemours (NYSE:DD) SVP Erik Hoover Sells 6,005 Shares**
- Source: MarketBeat | 20251202T225620 | Neutral | Relevance: 100%
- DuPont de Nemours SVP Erik Hoover sold 6,005 shares of DD stock for approximately $238,938.95, reducing his stake by 5.08%. The company recently authorized a $2.00 billion share buyback and declared a quarterly dividend of $0.20 per share. Analysts generally rate DD as a "Moderate Buy" with an average target price of $42.88.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 3, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | RBC Capital | $48 | $100 | -52% |
| 2025-11-07 | Wells Fargo | $50 | $100 | -50% |
| 2025-11-07 | UBS | $46 | $44 | +5% |
| 2025-11-07 | Keybanc | $45 | $44 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | RBC Capital | main | Outperform |
| 2025-11-07 | Wells Fargo | main | Overweight |
| 2025-11-07 | UBS | main | Buy |
| 2025-11-07 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 11 ($0.35M) |
| Sells | 3 ($0.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+6.7%)
- Blackrock Inc.: 7.6% (-5.1%)
- State Street Corpora: 4.3% (-0.9%)
- Geode Capital Manage: 2.6% (+1.5%)
- Nuveen, LLC: 2.1% (+7.4%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.5% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +8%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.78 indicates undervaluation relative to growth. Forward P/E 18.3x attractive for 25% earnings growth. Analyst sentiment negative (4 target cuts vs 3 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.3B |
| Beta | 1.14 |
| 52W Range | $22.50 - $41.85 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.78 |
| Forward P/E | 18.3 |
| Current P/E | 23.0 |
| YoY Growth | 25.5% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 1.9% to -0.7% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.7pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: =DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.65% (CS: 45) | Neutral |
| RSI_14 | 62.3 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 1.111x | Above |
| vs SMA200 | 1.259x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.66
- **Stop Loss:** $37.56 (5.3% risk)
- **Target:** $41.76 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 452
- **Position Value:** $17,926.32
- **Portfolio %:** 17.93%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-10 (Est: $0.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.98 | $1.09 | +11.2% |
| 2025Q2 | $1.06 | $1.12 | +5.5% |
| 2025Q1 | $0.95 | $1.03 | +8.1% |
| 2024Q4 | $0.98 | $1.13 | +15.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*